Xylazine premedication does not modify the onset and duration of cisatracurium blockade in anaesthetized dogs.
The purpose of this study was to evaluate the effect of xylazine as premedication on the onset time and duration of cisatracurium neuromuscular blockade in anaesthetized dogs. This study was carried out on 12 healthy dogs aged 0.5-6 years and weighing 9-26 kg undergoing various elective surgical procedures. The dogs were randomly divided into two groups of t (test) and c (control), with six dogs each. In group t, premedication was conducted using acepromazine maleate 0.3 mg kg(-1) and xylazine 0.3 mg kg(-1) and in group c only acepromazine (same dose) was injected intramuscularly 20 min before general anaesthesia. After induction with thiopental, anaesthesia was maintained with halothane in oxygen to deliver an end-tidal halothane concentration of 1.1%. Neuromuscular blockade was induced with cisatracurium 0.2 mg kg(-1) and monitored using the train-of-four (TOF) stimulation pattern applied at the ulnar nerve. The onset time of cisatracurium blockade was 195 +/- 85.44 s in test and 153.3 +/- 38.16 s in control group. The duration of neuromuscular blockade was 24.8 +/- 4.79 min in t and 28.3 +/- 5.46 min in the c group. Statistical analysis of the data showed no significant difference between groups in terms of onset and duration of neuromuscular blockade.
Kariman
A
A
Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran. akariman@ut.ac.ir
Shahabeddin
M
M
D000075:Acepromazine / Q000008:administration & dosage; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage*; D000818:Animals; D001279:Atracurium / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004285:Dogs; D005260:Female; D007273:Injections, Intramuscular / Q000662:veterinary; D008297:Male; D009407:Nerve Block / Q000379:methods / Q000662:veterinary*; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage*; D011292:Premedication / Q000379:methods / Q000662:veterinary; D011897:Random Allocation; D013997:Time Factors; D014991:Xylazine / Q000008:administration & dosage*
D000316:Adrenergic alpha-Agonists; D009466:Neuromuscular Blocking Agents; D001279:Atracurium; D014991:Xylazine; D000075:Acepromazine; C101584:cisatracurium